Inflammatory processes in renal fibrosis - PubMed (original) (raw)
Review
. 2014 Sep;10(9):493-503.
doi: 10.1038/nrneph.2014.114. Epub 2014 Jul 1.
Affiliations
- PMID: 24981817
- DOI: 10.1038/nrneph.2014.114
Review
Inflammatory processes in renal fibrosis
Xiao-Ming Meng et al. Nat Rev Nephrol. 2014 Sep.
Abstract
Many types of kidney injury induce inflammation as a protective response. However, unresolved inflammation promotes progressive renal fibrosis, which can culminate in end-stage renal disease. Kidney inflammation involves cells of the immune system as well as activation of intrinsic renal cells, with the consequent production and release of profibrotic cytokines and growth factors that drive the fibrotic process. In glomerular diseases, the development of glomerular inflammation precedes interstitial fibrosis; although the mechanisms linking these events are poorly understood, an important role for tubular epithelial cells in mediating this link is gaining support. Data have implicated macrophages in promoting both glomerular and interstitial fibrosis, whereas limited evidence suggests that CD4(+) T cells and mast cells are involved in interstitial fibrosis. However, macrophages can also promote renal repair when the cause of renal injury can be resolved, highlighting their plasticity. Understanding the mechanisms by which inflammation drives renal fibrosis is necessary to facilitate the development of therapeutics to halt the progression of chronic kidney disease.
Similar articles
- Mast cell activation and degranulation promotes renal fibrosis in experimental unilateral ureteric obstruction.
Summers SA, Gan PY, Dewage L, Ma FT, Ooi JD, O'Sullivan KM, Nikolic-Paterson DJ, Kitching AR, Holdsworth SR. Summers SA, et al. Kidney Int. 2012 Sep;82(6):676-85. doi: 10.1038/ki.2012.211. Epub 2012 Jun 6. Kidney Int. 2012. PMID: 22673890 - Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease.
Furuichi K, Kaneko S, Wada T. Furuichi K, et al. Clin Exp Nephrol. 2009 Feb;13(1):9-14. doi: 10.1007/s10157-008-0119-5. Epub 2008 Dec 16. Clin Exp Nephrol. 2009. PMID: 19085040 Review. - Lipopolysaccharide-pretreated plasmacytoid dendritic cells ameliorate experimental chronic kidney disease.
Zheng D, Cao Q, Lee VW, Wang Y, Zheng G, Wang Y, Tan TK, Wang C, Alexander SI, Harris DC, Wang Y. Zheng D, et al. Kidney Int. 2012 May;81(9):892-902. doi: 10.1038/ki.2011.471. Epub 2012 Feb 8. Kidney Int. 2012. PMID: 22318423 Free PMC article. - Nicotinamide reduces renal interstitial fibrosis by suppressing tubular injury and inflammation.
Zheng M, Cai J, Liu Z, Shu S, Wang Y, Tang C, Dong Z. Zheng M, et al. J Cell Mol Med. 2019 Jun;23(6):3995-4004. doi: 10.1111/jcmm.14285. Epub 2019 Apr 16. J Cell Mol Med. 2019. PMID: 30993884 Free PMC article. - From inflammation to renal fibrosis: A one-way road in autoimmunity?
Roccatello D, Lan HY, Sciascia S, Sethi S, Fornoni A, Glassock R. Roccatello D, et al. Autoimmun Rev. 2024 Apr;23(4):103466. doi: 10.1016/j.autrev.2023.103466. Epub 2023 Oct 15. Autoimmun Rev. 2024. PMID: 37848157 Review.
Cited by
- Potential therapeutic impacts of vitamin D on hypothyroid-induced heart and kidney fibrosis and oxidative status in male rat.
Rastegar-Moghaddam SH, Akbarian M, Rajabian A, Alipour F, Hojjati Shargh A, Masoomi R, Ebrahimzadeh Bideskan A, Hosseini M. Rastegar-Moghaddam SH, et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov 13. doi: 10.1007/s00210-024-03593-8. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39535596 - GSDMD Mediates Ang II-Induced Hypertensive Nephropathy by Regulating the GATA2/AQP4 Signaling Pathway.
Fan X, Zhang W, Zheng R, Zhang Y, Lai X, Han J, Fang Z, Han B, Huang W, Ye B, Dai S. Fan X, et al. J Inflamm Res. 2024 Nov 5;17:8241-8259. doi: 10.2147/JIR.S488553. eCollection 2024. J Inflamm Res. 2024. PMID: 39525316 Free PMC article. - Lipid metabolism disorders and albuminuria risk: insights from National Health and Nutrition Examination Survey 2001-2018 and Mendelian randomization analyses.
Wang Y, Li S. Wang Y, et al. Ren Fail. 2024 Dec;46(2):2420841. doi: 10.1080/0886022X.2024.2420841. Epub 2024 Nov 3. Ren Fail. 2024. PMID: 39491271 Free PMC article. - Contribution of ECT2 to Tubulointerstitial Fibrosis in the Progression of Chronic Kidney Disease.
Song KX, Su H. Song KX, et al. Curr Med Sci. 2024 Oct 26. doi: 10.1007/s11596-024-2948-1. Online ahead of print. Curr Med Sci. 2024. PMID: 39460889 - Impact of immunosuppressive drugs on efficacy of mesenchymal stem cell therapy for suppressing renal fibrosis.
Miyasako K, Nakashima A, Ishiuchi N, Tanaka Y, Morimoto K, Sasaki K, Nagamatsu S, Matsuda G, Masaki T. Miyasako K, et al. Stem Cells Transl Med. 2024 Nov 12;13(11):1067-1085. doi: 10.1093/stcltm/szae073. Stem Cells Transl Med. 2024. PMID: 39401338 Free PMC article.
References
- J Am Soc Nephrol. 2012 Feb;23(2):194-203 - PubMed
- Annu Rev Med. 2006;57:365-80 - PubMed
- J Am Soc Nephrol. 2011 Jul;22(7):1262-74 - PubMed
- Scand J Immunol. 2001 Apr;53(4):386-92 - PubMed
- Nat Med. 2013 Aug;19(8):1047-53 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials